首页> 外国专利> Use for drug acarbose precose for weight control prevention of weight gain for weight loss for treatment and prevention of obesity

Use for drug acarbose precose for weight control prevention of weight gain for weight loss for treatment and prevention of obesity

机译:阿卡波糖药物用于控制体重,预防体重增加,减轻体重,治疗和预防肥胖的用途

摘要

Control of weight gain has long been a problem for many people who if they lose weight by dieting often gain it back in a short period of time. Therefore, there has been much research to find a simple means to control weight in humans.;Acarbose, an oligosaccharide, is an oral alpha glucosidase inhibitor. The mechanism of action of acarbose results from a competitive inhibition of pancreatic amylase and membrane bound intestinal aplpha-glucoside hydrolase enzymes. Pancreatic alpha amylase hydrolizes complex starches in the lumen of the small intestine. The membrane bound intestinal alpha glucosidases hydrolyze oligo saccharides, trissaccharides and disaccharides to glucose and other monosaccharides in the brush boarder of the small intestines. It has no inhibitory effect against lactase and would therefore not be expected to induce the symptoms of lactose intolerance. The weight gain or loss for an individual is essentially the difference between the calories absorbed and the calories burned.
机译:长期以来,控制体重增加一直是许多人的难题,如果他们通过节食减轻体重,往往会在短时间内恢复体重。因此,已经进行了许多研究以找到控制人体体重的简单方法。阿卡波糖(一种低聚糖)是一种口服α-葡萄糖苷酶抑制剂。阿卡波糖的作用机理是由竞争性抑制胰淀粉酶和膜结合的肠内Aplpha-葡萄糖苷水解酶引起的。胰α淀粉酶水解小肠腔内的复杂淀粉。膜结合肠α-葡萄糖苷酶将小肠刷壁中的寡糖,三糖和二糖水解为葡萄糖和其他单糖。它对乳糖酶没有抑制作用,因此不会引起乳糖不耐症的症状。一个人的体重增加或减少实质上是吸收的卡路里与燃烧的卡路里之间的差。

著录项

  • 公开/公告号US6387361B1

    专利类型

  • 公开/公告日2002-05-14

    原文格式PDF

  • 申请/专利权人 ROSNER HARVEY;

    申请/专利号US19990364992

  • 发明设计人 HARVEY ROSNER;

    申请日1999-08-02

  • 分类号A61K317/40;

  • 国家 US

  • 入库时间 2022-08-22 00:49:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号